EHMT2 and breast cancer: Our transcriptomic analysis of G9a-inhibited BC cells supports previous findings by revealing G9a’s critical role in maintaining ER activity in ER-positive BC cells and promoting ECM signaling pathways in both ER-positive and -negative BC cells (Table S5).